Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).
作者:
主题词
人类(Humans);癌, 移行细胞(Carcinoma, Transitional Cell);倾向性评分(Propensity Score);回顾性研究(Retrospective Studies);队列研究(Cohort Studies);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1111/iju.15014
PMID
35996761
发布时间
2023-04-13
- 浏览0

International journal of urology
1462-1469页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文